investment.com

4D Molecular Therapeutics, Inc. — insider transactions

16 transactions on record · FDMT · CIK 1650648

Aggregates

computed from the filings below
Purchases, 12m
0
count of open-market buys
Sales, 12m
16
count of open-market sales
Buy / sell ratio, 12m
0.00
purchases per sale
Distinct insiders, 12m
2
Bought, 3m
$0
Sold, 3m
$3.3M
Median disclosure lag
2.0 d
trade date to filing date
Largest single trade, 24m
$811K
2026-09-14
Director share, 12m
62.5%
of transactions where role is stated
Current run
16 sells
consecutive same-direction transactions
Net 3m flow
-$3.3M
purchases minus sales
Total on record
16

Transactions

16 most recent shown
DisclosedTradedLag, dInsiderRoleTransactionSharesPriceValueSource
2026-09-162026-09-142Kirn DavidDirector, See RemarksOpen market sale58,333$13.90$811Kfiling
2026-08-212026-08-192Kirn DavidDirector, See RemarksOpen market sale25,927$16.42$425.7Kfiling
2026-08-212026-08-192Kirn DavidDirector, See RemarksOpen market sale43,149$15.36$662.6Kfiling
2026-08-212026-08-192Kirn DavidDirector, See RemarksExercise of derivative50,000$4.14$207Kfiling
2026-08-212026-08-192Kirn DavidDirector, See RemarksExercise of derivative50,000$0.00—filing
2026-08-172026-08-134Bizily ScottChief Legal OfficerExercise of derivative1,635$4.14$6.8Kfiling
2026-08-172026-08-134Bizily ScottChief Legal OfficerOpen market sale1,635$12.00$19.6Kfiling
2026-08-172026-08-170Bizily ScottChief Legal OfficerExercise of derivative1,635$4.14$6.8Kfiling
2026-08-172026-08-170Bizily ScottChief Legal OfficerOpen market sale1,635$12.20$19.9Kfiling
2026-08-172026-08-134Bizily ScottChief Legal OfficerExercise of derivative1,635$0.00—filing
2026-08-172026-08-170Bizily ScottChief Legal OfficerExercise of derivative1,635$0.00—filing
2026-08-052026-08-041Kirn DavidDirector, See RemarksOpen market sale26,842$10.23$274.6Kfiling
2026-08-042026-08-031Kirn DavidDirector, See RemarksOpen market sale12,415$10.05$124.7Kfiling
2026-07-142026-07-104Kirn DavidDirector, See RemarksOpen market sale15,283$12.01$183.6Kfiling
2026-07-142026-07-095Kirn DavidDirector, See RemarksOpen market sale42,608$12.87$548.2Kfiling
2026-07-142026-07-104Kirn DavidDirector, See RemarksOpen market sale442$12.84$5.7Kfiling

Source: U.S. Securities and Exchange Commission, EDGAR

4D Molecular Therapeutics, Inc. insider transactions — 16 filings on record — investment.com